Setara Biosciences, Inc. raised $90 million in a Series A financing to advance precision medicines for rare genetic diseases.
Amount Raised
$90 Million
Round Type
Series A
San DiegoBiotechnologyHealth CareTherapeuticsDescription
Setara Biosciences, Inc. has completed a $90 million Series A financing. The company focuses on developing precision medicines for severe rare diseases. This funding will support the advancement of its pipeline, including investigational therapies for specific genetic conditions.
Who to call at Setara Biosciences, and when
A new round usually means Setara Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Setara Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Setara Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Setara Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Setara Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansSetara Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.